Lim Bryant David
SEC CIK 1752888 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PRLD | Prelude Therapeutics Inc | CLO, Interim CFO, Corp Sec | 27.4K | $35.7K | — | 2 | 2023-05-24 | 2024-12-19 |
Most active insiders at PRLD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Bonita David P | Dir, 10% | $12.50M | — |
| 2 | ORBIMED ADVISORS LLC | Dir, 10% | $12.50M | — |
| 3 | Huang Jane | Pres, CMO | — | — |
| 4 | RA CAPITAL MANAGEMENT, L.P. | 10% | — | — |
Lim Bryant David made no open-market trades at PRLD in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-20 | 2024-12-19 | PRLD | Prelude Therapeutics Inc | Lim Bryant David | CLO, Interim CFO, Corp Sec | P - Purchase | $0.91 | +25.0K | 27.4K | +1,042% | +$22.8K | |
| 2023-05-25 | 2023-05-24 | PRLD | Prelude Therapeutics Inc | Lim Bryant David | CLO, Corp Sec | P - Purchase | $5.39 | +2,400 | 2,400 | New | +$12.9K |
Purchase Sale Sale after option exercise All abbreviations